![](http://elea-en.com.vnct3013.avnam.net/wp-content/uploads/Pack-Bevax-400-x-16.png)
Bevax
Antineoplastic. Anti VEGF monoclonal antibody. Indicated to treat patients with advanced or metastatic tumors such as: colorectal cancer, lung cancer, glioblastoma, ovary cancer, renal cancer, cervix cancer.
Therapeutic Area
Oncology
Active Ingredient
Bevacizumab
Line
Oncology
Pharmaceutical Forms
1 ampoule with 4 ml solution (100 mg)
1 ampoule with 16 ml solution (400 mg)
Solution 25 mg/ml.
![Descargar](http://elea-en.com.vnct3013.avnam.net/wp-content/themes/elea/img/arrow-blue.png)